Alan Dunton's Trading History
| CRMDCormedix | Jan 27, 2026 | Director | Uninformative Buy | ― | $402.65K | |
| PTNPalatin Technologies | Dec 11, 2025 | Director | Uninformative Buy | ― | $70.41K | |
| OGENOragenics | Dec 09, 2024 | Director | Informative Sell | 23.76 | $9.58K | |
| GYREGyre Therapeutics | Dec 12, 2014 | Director | Uninformative Buy | ― | $45.55K | |
| IMNPQImmune Pharmaceuticals | Aug 14, 2013 | ― | Uninformative Buy | ― | $7.05K | |
| MNOVMedicinova | ― | Director | ― | $0.00 |
You May Also Like
Alan Dunton insider profile FAQ
What is the percentage of profitable transactions made by Alan Dunton?
The percentage of profitable transactions made by Alan Dunton is 92%.
What is the average return per transaction made by Alan Dunton?
The average return per transaction made by Alan Dunton is 61.20%.
What stocks does Alan Dunton hold?
Alan Dunton holds: PTN, CRMD, GYRE, IMNPQ, OGEN, MNOV stocks.
What was Alan Dunton's most profitable transaction?
Alan Dunton’s most profitable transaction was an Informative Buy of CRMD stock on December 18, 2023. The return on the trade was 150.60%.
What is Alan Dunton's role in Palatin Technologies?
Alan Dunton's role in Palatin Technologies is Director.
How can I follow the stock ratings of top corporate insiders?
Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.
TipRanks measures corporate insiders by the stock transactions they report to the SEC. See how TipRanks ranks experts and calculates performance.